Skip to content
Research Article Open access CC BY 4.0

Intestinal Dysbiosis in Systemic Inflamation and Possibilities of Its Correction with Probiotics

K. Gorobchenko, A. Dyachenko

Microbiology Research Journal International · pp. 1–9 · Published 12 Jul 2017

10.9734/MRJI/2017/34534

Abstract

Aims: To estimate intestinal microbial changes and study the efficacy of probiotic preparations in systemic inflammation. Study Design: Cohort design. Place and Duration of Study: Sumy State University, Medical Institute. Department of Microbiology and Clinical Immunology, Kharkiv Medical Academy of Postgraduate Education. Methodology: The study involved 162 patient with chronic infections various sites, including 58 (35.8%) patients with respiratory tract infections, 56 (34.6%) patients with infections of the genitourinary system, and 48 (29.6%) - with purulent inflammatory postoperative complications. We studied the quantitative and qualitative composition of intestinal microflora on the background correction of probiotic preparations. Results: We have found quantitative and qualitative changes of intestinal microflora in all patients with chronic infections. Dysbiotic changes manifested in reducing the number of major orders symbionts (Lactobacillus spp., Bifidobacterium spp, Escherichia coli with normal enzymatic properties) and increase the number of pathogenic microorganisms (Staphylococcus aureus, Clostridium spp., Candida spp.). In all study groups after using probiotics, the number of pathogenic microorganisms (S. aureus, S. saprophyticus, S. epidermidis, C. albicans, and Cl. perfringens) were decreased and tended to restore normal range of microbial landscape. Conclusion: So, dysbiotic disorders of the intestine in patients with chronic inflammation characterized by decrease in the number of basic gut symbionts and reducing its protective properties that accompanied the advent of pathogenic microorganisms. In our study probiotics demonstrated statistically significant improvements in the qualitative and quantitative composition of microflora.

Microflora dysbiotic changes probiotics systemic inflammation.

References (18)

  1. 1 The Human Microbiome Project [DOI]
  2. 2 Host-Bacterial Mutualism in the Human Intestine [DOI]
  3. 3 Gut Microbiota in Health and Disease [DOI]
  4. 4 Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites [DOI]
  5. 5 Human nutrition, the gut microbiome and the immune system [DOI]
  6. 6 Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells [DOI]
  7. 7 In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings [DOI]
  8. 8 Western diet induces dysbiosis with increased E coli in CEABAC10 mice , alters host barrier function favouring AIEC colonisation [DOI]
  9. 9 Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis [DOI]
  10. 10 Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Infections by Probiotics [DOI]
  11. 11 Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn’s Disease [DOI]
  12. 12 Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease [DOI]
  13. 13 Probiotic/Synbiotic Therapy for Treating Critically Ill Patients from a Gut Microbiota Perspective [DOI]
  14. 14 Induction of Th17 cells by segmented filamentous bacteria in the murine intestine [DOI]
  15. 15 Mechanisms of Action of Probiotics in Intestinal Diseases [DOI]
  16. 16 The Dietary Polysaccharide Maltodextrin Promotes Salmonella Survival and Mucosal Colonization in Mice [DOI]
  17. 17 The Human Microbiome and Probiotics: Implications for Pediatrics [DOI]
  18. 18 Evaluation of the effects of a probiotic supplementation with respect to placebo on intestinal microflora and secretory IgA production, during antibiotic therapy, in children affected by recurrent airway infections and skin symptoms.

Cited by 1

The gut-prostate axis in benign prostatic hyperplasia: systematic review of microbial dysbiosis and pathogenic mechanisms

Yuanzhao Xu, Lingyue An, Ji-Ling Xie · BMC Urology · 2026

Related research

Article metrics

Real usage data collected on this platform.

63

Page views

0

PDF downloads

16

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.